论文部分内容阅读
由于ＥＢ病毒（ＥＢＶ）糖蛋白ｇp３５０／２２０是人类自然感染后ＥＢＶ中和抗体的主要攻击目标，并且在动物模型中已显示某些形式的ＰＰ３５０／２２０可抵抗ＥＢＶ相关疾病，因此，ＰＰ３５０／２２０有可能成为候选的ＥＢＶ亚单位疫苗。ＰＰ３５０／ｇｐ２２０是由单一基因
Since the Epstein-Barr virus (EBV) glycoprotein gp350 / 220 is the main target of EBV neutralizing antibodies after natural infection in humans and some forms of PP350 / 220 have been shown to be resistant to EBV-related diseases in animal models, PP350 / 220 It is possible to be a candidate EBV subunit vaccine. PP350 / gp220 is a single gene